[1]
“Clinical and pharmacoeconomic profile of lanthanum carbonate treatment of hyperphosphataemia in chronic renal dialysis patients”, FE, vol. 11, no. 1, pp. 13–26, Mar. 2010, doi: 10.7175/fe.v11i1.177.